Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,136,479 papers from all fields of science
Search
Sign In
Create Free Account
t(14;16)
A chromosomal translocation that involves the chromosomes 14 and 16.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Chromosomes, Human, Pair 14
Chromosomes, Human, Pair 16
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Efficacy of daratumumab in combination with lenalidomide plus dexamethasone (DRd) or bortezomib plus dexamethasone (DVd) in relapsed or refractory multiple myeloma (RRMM) based on cytogenetic risk…
K. Weisel
,
J. Miguel
,
+17 authors
M. Dimopoulos
2017
Corpus ID: 79494361
8006Background: In 2 randomized phase 3 trials of RRMM patients (pts), DRd (POLLUX) or DVd (CASTOR) significantly improved PFS…
Expand
2017
2017
Autologous Stem Cell Transplantation Versus Bortezomib-Melphalan-Prednisone for Newly Diagnosed Multiple Myeloma: Second Interim Analysis of the Phase 3 EMN02/HO95 Study
M. Cavo
,
R. Hájek
,
+22 authors
P. Sonneveld
2017
Corpus ID: 220332375
BackgroundThe EMN02/HO95 trial is the largest multicenter, randomized, phase 3 study conducted in the novel agent era and aimed…
Expand
2011
2011
Impact of high‐risk classification by FISH: an Eastern Cooperative Oncology Group (ECOG) study E4A03
S. Jacobus
,
Shaji K. Kumar
,
+9 authors
R. Fonseca
British Journal of Haematology
2011
Corpus ID: 34603673
Lenalidomide with dexamethasone is a standard induction treatment regimen for newly diagnosed myeloma (although a Federal Drug…
Expand
Review
2007
Review
2007
Management of newly diagnosed myeloma.
S. Vincent Rajkumar
,
A. Palumbo
Hematology/Oncology Clinics of North America
2007
Corpus ID: 11307388
2007
2007
Anomalies génétiques dans le myélome : rôle dans l'oncogenèse et implications pronostiques
O. Decaux
,
L. Lodé
,
S. Minvielle
,
H. Avet-Loiseau
2007
Corpus ID: 72115217
Highly Cited
2006
Highly Cited
2006
Analysis of PTEN deletions and mutations in multiple myeloma.
Hong Chang
,
X. Qi
,
J. Claudio
,
L. Zhuang
,
B. Patterson
,
A. K. Stewart
Leukemia research : a Forum for Studies on…
2006
Corpus ID: 27999103
Review
2006
Review
2006
Clinical implications of chromosomal abnormalities in multiple myeloma
E. Terpos
,
V. Eleutherakis-Papaiakovou
,
M. Dimopoulos
Leukemia and Lymphoma
2006
Corpus ID: 35306606
The adverse prognostic role of cytogenetic abnormalities has recently been established in plasma cell dyscrasias. Modern…
Expand
2006
2006
Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups.
G. Bisping
,
M. Kropff
,
+16 authors
J. Kienast
Blood
2006
Corpus ID: 2029519
In multiple myeloma (MM), both vascular endothelial (VEGF) and basic fibroblast growth factor (bFGF) promote tumor growth and…
Expand
2006
2006
The role of cytogenetics in myeloma
F. Zhan
,
J. Sawyer
,
G. Tricot
Leukemia
2006
Corpus ID: 32666315
Multiple myeloma is a slowly proliferating disease of ‘mature B cells’, involving mainly the bone marrow. Active myeloma is often…
Expand
1976
1976
Tertiary trisomy, 47,XX,+14q-, resulting from maternal balanced translocation, 46,XX,t(14;16)(q11;q24)
S. Young
,
D. Donovan
,
H. A. Greer
,
K. Burch
,
David C. Potter
Human Genetics
1976
Corpus ID: 31289233
SummaryA 3-year-old child with tertiary trisomy 14 (+14q-), daughter of a mother with a balanced reciprocal translocation [46,XX…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE